Sepsis definitions: time for change, Lancet, vol.381, p.774, 2013. ,
Sepsis in European intensive care units: results of the SOAP study, Critical care medicine, vol.34, pp.344-353, 2006. ,
Sepsis and septic shock, Nature reviews Disease primers, vol.2, p.16045, 2016. ,
The pathophysiology and treatment of sepsis, New England Journal of Medicine, vol.348, pp.138-150, 2003. ,
The immunopathology of sepsis and potential therapeutic targets, Nature Reviews Immunology, vol.17, p.407, 2017. ,
Early goal-directed therapy in the treatment of severe sepsis and septic shock, New England Journal of Medicine, vol.345, pp.1368-1377, 2001. ,
Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department, Critical care medicine, vol.38, pp.1045-1053, 2010. ,
Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial, Jama, vol.282, pp.54-61, 1999. ,
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia, Nature, vol.330, p.662, 1987. ,
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group, Critical care medicine, vol.21, pp.318-327, 1993. ,
Efficacy and safety of monoclonal antibody to human tumor necrosis factor ? in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial, Jama, vol.273, pp.934-941, 1995. ,
Steroids in the treatment of clinical septic shock, Annals of surgery, vol.184, p.13, 1976. ,
The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study, New England Journal of Medicine, vol.311, pp.1137-1143, 1984. ,
Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin. The Lancet, vol.323, pp.981-983, 1984. ,
Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli, New England Journal of Medicine, vol.307, pp.1225-1230, 1982. ,
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial, Jama, vol.290, pp.238-247, 2003. ,
for the recombinant human activated protein C worldwide evaluation in severe sepsis (PROWESS) study group, N Engl J Med, vol.344, pp.699-709, 2001. ,
The Effect of Vitamin C on Clinical Outcome in Critically Ill Patients: A Systematic Review With Meta-Analysis of Randomized Controlled Trials, Critical care medicine, vol.47, pp.774-783, 2019. ,
Oxidative stress and role of antioxidant supplementation in critical illness, Clinical laboratory, vol.53, pp.199-209, 2007. ,
Strategies to improve drug development for sepsis, Nature Reviews Drug Discovery, vol.13, p.741, 2014. ,
Invited review: Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicologic pathology, vol.30, pp.620-650, 2002. ,
Redox characteristics of the eukaryotic cytosol, Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, vol.1783, pp.629-640, 2008. ,
Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock, Clinical pharmacokinetics, vol.41, p.24, 2002. ,
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. The American journal of medicine, vol.115, pp.529-535, 2003. ,
Crucial role for ecto-5?-nucleotidase (CD73) in vascular leakage during hypoxia, Journal of Experimental Medicine, vol.200, p.26, 2004. ,
Activation of A2A adenosine receptors inhibits expression of ?4/?1 integrin (very late antigen-4) on stimulated human neutrophils, Journal of leukocyte biology, vol.75, pp.127-134, 2004. ,
Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes, The Journal of Immunology, vol.155, pp.2579-2586, 1995. ,
A2B adenosine receptors in immunity and inflammation, Trends in immunology, vol.30, pp.263-270, 2009. ,
Minireview: nanoparticles and the immune system, Endocrinology, vol.151, pp.458-465, 2010. ,
, Nanoparticles for immune system targeting. Drug discovery today, vol.22, pp.1295-1301, 2017.
Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation, Science translational medicine, vol.7, p.32, 2015. ,
Prevention of vascular inflammation by nanoparticle targeting of adherent neutrophils, Nature nanotechnology, vol.9, p.204, 2014. ,
Regulation of the expression of Fc? receptor on circulating neutrophils and monocytes in Kawasaki disease, Clinical and experimental immunology, vol.117, p.418, 1999. ,
Bioresponsive Nanoparticles Targeted to Infectious Microenvironments for Sepsis Management, Advanced Materials, vol.30, p.1803618, 2018. ,
Anti-inflammatory agents: present and future, Cell, vol.140, pp.935-950, 2010. ,
Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics, ACS nano, vol.6, pp.4279-4287, 2012. ,
Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery, Journal of the American Chemical Society, vol.134, p.38, 2012. ,
Exosomes in critical illness, Critical care medicine, vol.45, pp.1054-1060, 2017. ,
Functional significance of exosomes applied in sepsis: A novel approach to therapy, Biochimica et Biophysica Acta, vol.1863, pp.292-297, 2017. ,
Exosome-delivered microRNAs modulate the inflammatory response to endotoxin, Nature communications, vol.6, p.7321, 2015. ,
Exosomal miR-223 contributes to mesenchymal stem cellelicited cardioprotection in polymicrobial sepsis, Scientific reports, vol.5, p.13721, 2015. ,
Manufacturing exosomes: a promising therapeutic platform, Trends in molecular medicine, vol.24, pp.242-256, 2018. ,
Application of Deacetylated Poly-N-Acetyl Glucosamine Nanoparticles for the Delivery of miR-126 for the Treatment of Cecal Ligation and Puncture-Induced Sepsis, Inflammation, vol.42, pp.170-184, 2019. ,
Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice, Nature biotechnology, vol.33, p.45, 2015. ,
A biomimetic nanosponge that absorbs pore-forming toxins, Nature nanotechnology, vol.8, p.336, 2013. ,
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform, Proceedings of the National Academy of Sciences, vol.108, pp.10980-10985, 2011. ,
Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management, Proceedings of the National Academy of Sciences, vol.114, pp.11488-11493, 2017. ,
Engineered nanoparticles disguised as macrophages for trapping lipopolysaccharide and preventing endotoxemia, Biomaterials, vol.189, pp.60-68, 2019. ,
Nanocarriers for antibiotics: A promising solution to treat intracellular bacterial infections, International journal of antimicrobial agents, vol.43, pp.485-496, 2014. ,
Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era, Journal of controlled release, vol.156, p.51, 2011. ,
Liposomes as delivery systems for antibiotics, International journal of pharmaceutics, vol.387, pp.187-198, 2010. ,
Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection, Biomacromolecules, vol.14, pp.1103-1112, 2013. ,
The interaction of bacterial pathogens with platelets, Nature Reviews Microbiology, vol.4, p.445, 2006. ,
Nanoparticle biointerfacing by platelet membrane cloaking, Nature, vol.526, p.118, 2015. ,
Combating multidrug-resistant Gramnegative bacteria with structurally nanoengineered antimicrobial peptide polymers, Nature microbiology, vol.1, p.16162, 2016. ,
Ceria nanoparticles that can protect against ischemic stroke, Angewandte Chemie International Edition, vol.51, pp.11039-11043, 2012. ,
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides, Nature nanotechnology, vol.1, p.142, 2006. ,
Ceria-Zirconia Nanoparticles as an Enhanced Multi-Antioxidant for Sepsis Treatment, Angewandte Chemie International Edition, vol.56, p.59, 2017. ,
Antioxidative nanoparticles significantly enhance therapeutic efficacy of an antibacterial therapy against Listeria monocytogenes infection, Molecular pharmaceutics, vol.15, pp.1126-1132, 2018. ,
An electron paramagnetic resonance study of the antioxidant properties of the nitroxide free radical TEMPO. Free Radical Biology and Medicine, vol.15, p.61, 1993. ,
The cyclic nitroxide antioxidant 4-methoxy-TEMPO decreases mycobacterial burden in vivo through host and bacterial targets, Free Radical Biology and Medicine, 2019. ,
On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals, Physical Chemistry Chemical Physics, vol.13, pp.7178-7188, 2011. ,
Oxidation of melatonin by singlet molecular oxygen (O2 (1?g)) produces N1-acetyl-N2-formyl-5-methoxykynurenine, Journal of pineal research, vol.35, pp.131-137, 2003. ,
Melatonin synergistically increases resveratrol-induced heme oxygenase-1 expression through the inhibition of ubiquitin-dependent proteasome pathway: a possible role in neuroprotection, Journal of pineal research, vol.50, pp.110-123, 2011. ,
Changes in the amount of reduced glutathione and activity of antioxidant enzymes in chosen mouse organs influenced by zymosan and melatonin administration, Acta Biologica Hungarica, vol.62, pp.133-141, 2011. ,
Transdermal delivery of a pineal hormone: melatonin via elastic liposomes, Biomaterials, vol.27, pp.3491-3496, 2006. ,
Same molecule but different expression: aging and sepsis trigger NLRP3 inflammasome activation, a target of melatonin, Journal of pineal research, vol.60, pp.193-205, 2016. ,
Antioxidant potential of different melatonin-loaded nanomedicines in an experimental model of sepsis, Experimental Biology and Medicine, vol.237, pp.670-677, 2012. ,
Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in mice, Biomaterials, vol.144, pp.30-41, 2017. ,
Humanized mice in translational biomedical research, Nature Reviews Immunology, vol.7, p.118, 2007. ,
The clinical and immunological performance of 28 days survival model of cecal ligation and puncture in humanized mice, PloS one, vol.12, p.180377, 2017. ,
CP-0127, a novel potent bradykinin antagonist, increases survival in rat and rabbit models of endotoxin shock, Agents and actions. Supplements, vol.38, pp.413-420, 1992. ,
Precision immunotherapy for sepsis, Frontiers in immunology, vol.9, 2018. ,
Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles, Journal of Controlled Release, vol.307, pp.302-314, 2019. ,
URL : https://hal.archives-ouvertes.fr/cea-02294923
Drug delivery: too much complexity, not enough reproducibility?, Angewandte Chemie International Edition, vol.56, pp.15170-15171, 2017. ,
Immature dendritic cell-derived exosomes rescue septic animals via milk fat globule epidermal growth factor VIII, The Journal of immunology, vol.183, pp.5983-5990, 2009. ,
, Nanomaterials for Medicine. Therapeutic Nanomaterials, vol.1, 2016.
Multifunctional squalene-based prodrug nanoparticles for targeted cancer therapy, Chem Commun (Camb), vol.50, pp.5336-5338, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01325230
Nanoengineering of particle surfaces, Advanced Materials, vol.13, pp.11-22, 2001. ,
Nanocapsule formation by interfacial polymer deposition following solvent displacement, International journal of pharmaceutics, vol.55, pp.1-4, 1989. ,
The manufacturing techniques of various drug loaded biodegradable poly (lactide-coglycolide)(PLGA) devices, Biomaterials, vol.21, pp.2475-2490, 2000. ,
Microfluidic platform for controlled synthesis of polymeric nanoparticles, Nano letters, vol.8, pp.2906-2912, 2008. ,
The generation of nanoparticles in miniemulsions, Advanced Materials, vol.13, pp.765-768, 2001. ,
Large-scale synthesis of uniform and crystalline magnetite nanoparticles using reverse micelles as nanoreactors under reflux conditions, Advanced Functional Materials, vol.15, pp.503-509, 2005. ,
Ultra-large-scale syntheses of monodisperse nanocrystals, Nature materials, vol.3, pp.891-895, 2004. ,
Methods for the preparation and manufacture of polymeric nanoparticles, Pharmaceutical research, vol.26, pp.1025-1058, 2009. ,
Cation permeability of phospholipid model membranes: effect of narcotics, Nature, vol.208, pp.1295-1297, 1965. ,
Diffusion of univalent ions across the lamellae of swollen phospholipids, J Mol Biol, vol.13, pp.238-252, 1965. ,
The action of steroids and streptolysin S on the permeability of phospholipid structures to cations, J Mol Biol, vol.13, pp.253-259, 1965. ,
Recent advances with liposomes as pharmaceutical carriers, Nat Rev Drug Discov, vol.4, pp.145-160, 2005. ,
Polymer nanoparticles, Prog Mol Biol Transl Sci, vol.104, pp.299-323, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-02402169
Doxil(R)--the first FDA-approved nano-drug: lessons learned, J Control Release, vol.160, pp.117-134, 2012. ,
Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles, Journal of Controlled Release, vol.132, pp.171-183, 2008. ,
Cancer nanomedicine: progress, challenges and opportunities, Nature Reviews Cancer, vol.17, pp.20-37, 2016. ,
Nanopharmaceuticals (part 1): products on the market, Int J Nanomedicine, vol.9, pp.4357-4373, 2014. ,
The journey of a drug-carrier in the body: An anatomo-physiological perspective, Journal of Controlled Release, vol.161, pp.152-163, 2012. ,
Projections of global mortality and burden of disease from 2002 to 2030, PLoS Med, vol.3, p.442, 2006. ,
Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations, Int J Cardiol, vol.168, p.23, 2013. ,
Mechanisms of plaque formation and rupture, Circ Res, vol.114, pp.1852-1866, 2014. ,
Macrophages in the pathogenesis of atherosclerosis, Cell, vol.145, p.25, 2011. ,
Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies, Circ Res, vol.114, p.26, 2014. ,
Atherosclerosis: current pathogenesis and therapeutic options, Nat Med, vol.17, pp.1410-1422, 2011. ,
Mechanisms of thrombus formation, N Engl J Med, vol.359, pp.938-949, 2008. ,
Nanomedicine as a strategy to fight thrombotic diseases, Future Science OA, vol.1, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02438607
Myocardial ischemia-reperfusion injury: a neglected therapeutic target, J Clin Invest, vol.123, pp.92-100, 2013. ,
The mitochondrial permeability transition pore and ischemia-reperfusion injury, Basic Res Cardiol, vol.104, pp.181-188, 2009. ,
Lowering LDL-cholesterol through diet: potential role in the statin era, Curr Opin Lipidol, vol.22, pp.43-48, 2011. ,
Where does the interplay between cholesterol absorption and synthesis in the context of statin and/or ezetimibe treatment stand today?, Atherosclerosis, vol.217, pp.308-321, 2011. ,
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, vol.366, pp.1267-1278, 2005. ,
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease, N Engl J Med, vol.375, pp.1242-1252, 2016. ,
Osteoprotegerin Promotes Fibrous Cap Formation in Atherosclerotic Lesions of ApoE-Deficient Mice--Brief Report, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.29, pp.1478-1480, 2009. ,
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. The Lancet, vol.371, pp.987-997, 2008. ,
Implications of chemokines, chemokine receptors, and inflammatory lipids in atherosclerosis, Journal of Leukocyte Biology, vol.95, pp.575-585, 2014. ,
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies, European Heart Journal, vol.30, pp.2838-2844, 2009. ,
Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results, Eur Heart J, vol.36, pp.112-119, 2015. ,
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology, Cardiovasc Res, vol.98, pp.7-27, 2013. ,
Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy, Expert Opin Pharmacother, vol.13, p.42, 2012. ,
Antioxidants, statins, and atherosclerosis, Journal of the American College of Cardiology, vol.41, pp.1205-1210, 2003. ,
Why have antioxidants failed in clinical trials?, Am J Cardiol, vol.101, p.44, 2008. ,
Antiplatelet drugs in cardiological practice: established strategies and new developments. Vasc Health Risk Manag, vol.4, pp.637-645, 2008. ,
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration, Biomaterials, vol.29, pp.1912-1919, 2008. ,
Principles of nanoparticle design for overcoming biological barriers to drug delivery, Nature biotechnology, vol.33, pp.941-951, 2015. ,
Role of target geometry in phagocytosis, Proc Natl Acad Sci U S A, vol.103, pp.4930-4934, 2006. ,
Preparation, characterization and in vitro cytotoxicity of paclitaxelloaded sterically stabilized solid lipid nanoparticles, Biomaterials, vol.28, pp.2137-2146, 2007. ,
Interpretation of the evidence for the efficacy and safety of statin therapy, Lancet, vol.388, pp.2532-2561, 2016. ,
Alterations in the hepatic transcriptional landscape after RNAi mediated ApoB silencing in cynomolgus monkeys, Atherosclerosis, vol.242, pp.383-395, 2015. ,
RNAi-mediated gene silencing in nonhuman primates, Nature, vol.441, pp.111-114, 2006. ,
Specificity of short interfering RNA determined through gene expression signatures, Proceedings of the National Academy of Sciences, vol.100, pp.6347-6352, 2003. ,
An integrated encyclopedia of DNA elements in the human genome, Nature, vol.489, pp.57-74, 2012. ,
Photo-responsive block copolymer micelles: design and behavior, Chem Soc Rev, vol.42, pp.7117-7129, 2013. ,
Recent advances in nanoparticle-mediated siRNA delivery, Annu Rev Biomed Eng, vol.16, pp.347-370, 2014. ,
Recent progress in development of siRNA delivery vehicles for cancer therapy, Adv Drug Deliv Rev, vol.104, pp.61-77, 2016. ,
Targeting the Proprotein Convertase Subtilisin/Kexin Type 9 for the Treatment of Dyslipidemia and Atherosclerosis, Journal of the American College of Cardiology, vol.62, pp.1401-1408, 2013. ,
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates, Proceedings of the National Academy of Sciences, vol.105, pp.11915-11920, 2008. ,
Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebocontrolled, phase 1 trial. The Lancet, vol.383, pp.60-68, 2014. ,
Biodistribution of carbon single-wall carbon nanotubes in mice, J Nanosci Nanotechnol, vol.4, pp.1019-1024, 2004. ,
Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit, J Clin Invest, vol.85, pp.1234-1241, 1990. ,
High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits, Lab Invest, vol.60, pp.455-461, 1989. ,
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial, JAMA, vol.290, pp.2292-2300, 2003. ,
HDL-Mimetic PLGA Nanoparticle To Target Atherosclerosis Plaque Macrophages, Bioconjugate Chemistry, vol.26, pp.443-451, 2015. ,
, Pegylation of High-Density Lipoprotein Decreases Plasma Clearance and Enhances Antiatherogenic Activity, vol.113, pp.1-9, 2013.
Regulation of atherosclerotic plaque inflammation, J Intern Med, vol.278, pp.462-482, 2015. ,
Anti-inflammatory therapies for cardiovascular disease, Eur Heart J, vol.35, pp.1782-1791, 2014. ,
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites, Science, vol.325, pp.612-616, 2009. ,
Therapeutic siRNA silencing in inflammatory monocytes in mice, Nature Biotechnology, vol.29, pp.1005-1010, 2011. ,
, Monocyte-Directed RNAi Targeting CCR2 Improves Infarct Healing in Atherosclerosis-Prone Mice. Circulation, 2013.
VCAM-1 directed target-sensitive liposomes carrying CCR2 antagonists bind to activated endothelium and reduce adhesion and transmigration of monocytes.pdf, European Journal of Pharmateucis and Biopharmaceutics, 2015. ,
The combined role of P-and E-selectins in atherosclerosis, J Clin Invest, vol.102, pp.145-152, 1998. ,
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight, Nat Nanotechnol, vol.9, pp.648-655, 2014. ,
RNAi targeting multiple cell adhesion molecules reduces immune cell recruitment and vascular inflammation after myocardial infarction, Science Translational Medicine, vol.8, p.11, 2016. ,
Drug Insight: immunomodulatory effects of statins-potential benefits for renal patients?, Nature Clinical Practice Nephrology, vol.2, pp.378-387, 2006. ,
Mechanisms for the anti-inflammatory effects of statins, Curr Opin Lipidol, vol.22, pp.165-170, 2011. ,
A statin-loaded reconstituted highdensity lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation, Nat Commun, vol.5, p.3065, 2014. ,
, , vol.1, p.3
Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes, Circulation, vol.129, pp.896-906, 2013. ,
A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model, PLoS One, vol.10, p.132451, 2015. ,
Glucocorticosteroids: current and future directions, Br J Pharmacol, vol.163, pp.29-43, 2011. ,
Efficient drug delivery to atherosclerotic lesions and the antiatherosclerotic effect by dexamethasone incorporated into liposomes in atherogenic mice, Journal of drug targeting, vol.13, pp.267-276, 2005. ,
,
,
Multimodal Clinical Imaging To Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis.pdf, Molecular Pharmaceutics, 2010. ,
Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases, J Atheroscler Thromb, vol.23, pp.757-765, 2016. ,
Andersona,I, <Painting blood vessels and atherosclerotic plaques with an adhesive drug depot.pdf>, Proc Natl Acad Sci, 2012. ,
Resolution of inflammation: an integrated view, EMBO Molecular Medicine, vol.5, pp.661-674, 2013. ,
Cutting Edge: Humanized Nano-Proresolving Medicines Mimic Inflammation-Resolution and Enhance Wound Healing, The Journal of Immunology, vol.186, pp.5543-5547, 2011. ,
Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities, Science, vol.339, pp.166-172, 2013. ,
Annexin A1 and the Resolution of Inflammation: Modulation of Neutrophil Recruitment, Apoptosis, and Clearance, Journal of Immunology Research, pp.1-13, 2016. ,
Zahi Adel Fayadc, Ira Tabas, and Omid Cameron Farokhzad, Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles.pdf, Proc Natl Acad Sci, 2013. ,
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice, Science Translational Medicine, vol.7, pp.275-220, 2015. ,
Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis, ACS Nano, vol.10, pp.5280-5292, 2016. ,
Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery, Crit Care Med, vol.28, pp.2201-2208, 2000. ,
Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1, Am Heart J, vol.132, pp.747-757, 1996. ,
Cardioprotective effect of liposomal prostaglandin E1 on a porcine model of myocardial infarction reperfusion no-reflow, J Zhejiang Univ Sci B, vol.12, pp.638-643, 2011. ,
Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention, Chin Med J (Engl), vol.128, pp.1147-1150, 2015. ,
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction, J Am Coll Cardiol, vol.46, pp.125-133, 2005. ,
Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window, Cardiovasc Drugs Ther, vol.19, pp.243-250, 2005. ,
Erythropoietin in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomized, double-blind trial, Circ Cardiovasc Interv, vol.3, pp.408-413, 2010. ,
Intravenous erythropoietin in patients with STsegment elevation myocardial infarction: REVEAL: a randomized controlled trial, JAMA, vol.305, pp.1863-1872, 2011. ,
Single high-dose erythropoietin administration immediately after reperfusion in patients with ST-segment elevation myocardial infarction: results of the erythropoietin in myocardial infarction trial, Am Heart J, vol.163, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00811692
Postinfarct active cardiac-targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits, Am J Physiol Heart Circ Physiol, vol.304, pp.1124-1133, 2013. ,
Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair, Proc Natl Acad Sci U S A, vol.108, pp.1827-1832, 2011. ,
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, vol.33, pp.2569-2619, 2012. ,
Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status, Prog Cardiovasc Dis, vol.50, pp.352-382, 2008. ,
Plasminogen activator inhibitor-1 inhibitors: a patent review (2006-present), Expert Opin Ther Pat, vol.23, pp.801-815, 2013. ,
The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo, Thromb Res, vol.130, pp.576-585, 2012. ,
Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse, Eur J Neurosci, vol.34, pp.1085-1092, 2011. ,
Liposome accumulation in regions of experimental myocardial infarction, Science, vol.198, pp.735-738, 1977. ,
Liposome concentration in canine ischemic myocardium and depolarized myocardial cells, Circ Res, vol.49, pp.405-415, 1981. ,
Accelerated Thrombolysis and Reperfusion in a Canine Model of Myocardial Infarction by Liposomal Encapsulation of Streptokinase, Circulation Research, vol.66, pp.875-878, 1990. ,
, Delivery Systems for Biopharmaceuticals. Part I: Nanoparticles and Microparticles, vol.16, pp.940-954, 2015.
Encapsulation of a plasminogen activator speeds reperfusion, lessens infarct and reduces blood loss in a canine model of coronary artery thrombosis, Thromb Haemost, vol.91, pp.1213-1218, 2004. ,
Urokinase-coated chitosan nanoparticles for thrombolytic therapy: preparation and pharmacodynamics in vivo, J Thromb Thrombolysis, vol.36, pp.458-468, 2013. ,
Platelets directed liposomes for the delivery of streptokinase: development and characterization, Eur J Pharm Sci, vol.44, pp.589-594, 2011. ,
Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy, Pharm Res, vol.30, pp.1663-1676, 2013. ,
Construction and evaluation of Fe(3)O(4)-based PLGA nanoparticles carrying rtPA used in the detection of thrombosis and in targeted thrombolysis, ACS Appl Mater Interfaces, vol.6, pp.5566-5576, 2014. ,
Ultrasound-responsive thrombus treatment with zincstabilized gelatin nano-complexes of tissue-type plasminogen activator, J Drug Target, vol.20, pp.224-234, 2012. ,
Ultrasound identification and lysis of clots, Stroke, vol.35, pp.2722-2725, 2004. ,
Magnetically targeted thrombolysis with recombinant tissue plasminogen activator bound to polyacrylic acid-coated nanoparticles, Biomaterials, vol.30, pp.3343-3351, 2009. ,
Bioconjugation of recombinant tissue plasminogen activator to magnetic nanocarriers for targeted thrombolysis, Int J Nanomedicine, vol.7, pp.5159-5173, 2012. ,
Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator, Carbohydrate Polymers, vol.84, pp.364-372, 2011. ,
Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis, Wiley Interdiscip Rev Nanomed Nanobiotechnol, vol.1, pp.311-323, 2009. ,
Fabrication of novel biomaterials through molecular self-assembly, Nat Biotechnol, vol.21, pp.1171-1178, 2003. ,
Controlled delivery of PDGF-BB for myocardial protection using injectable self-assembling peptide nanofibers, J Clin Invest, vol.116, pp.237-248, 2006. ,
Sustained delivery of VEGF from designer selfassembling peptides improves cardiac function after myocardial infarction, Biochem Biophys Res Commun, vol.424, pp.105-111, 2012. ,
Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair, Sci Transl Med, vol.4, pp.146-109, 2012. ,
Non-viral vectors for gene-based therapy, Nat Rev Genet, vol.15, pp.541-555, 2014. ,
Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration, PLoS One, vol.7, p.39490, 2012. ,
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction, J Control Release, vol.132, pp.260-266, 2008. ,
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation, Cardiovasc Res, vol.108, pp.4-20, 2015. ,
Formulation and characterization of poly (D,L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery, J Clin Pharm Ther, vol.31, pp.43-48, 2006. ,
Injectable graphene oxide/hydrogel-based angiogenic gene delivery system for vasculogenesis and cardiac repair, ACS Nano, vol.8, pp.8050-8062, 2014. ,
Antioxidants in Cardiovascular Therapy: Panacea or False Hope? Front Cardiovasc Med, vol.2, p.29, 2015. ,
Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective, J Control Release, vol.113, pp.189-207, 2006. ,
) Function and Role in Heart Failure and Ischemic Heart Disease, Annu Rev Nutr, vol.35, issue.1, pp.175-213, 2015. ,
Acute administration of liposomal coenzyme Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury, J Surg Res, vol.79, pp.141-145, 1998. ,
Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction, Pharm Res, vol.24, pp.2131-2137, 2007. ,
Plug and seal: prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes, Nat Med, vol.1, pp.1195-1198, 1995. ,
Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction, Hypertension, vol.51, pp.319-325, 2008. ,
Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction, Biomaterials, vol.34, pp.7790-7798, 2013. ,
ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction, Pharm Res, vol.22, pp.2115-2120, 2005. ,
ATP-loaded immunoliposomes specific for cardiac myosin provide improved protection of the mechanical functions of myocardium from global ischemia in an isolated rat heart model, J Drug Target, vol.14, pp.273-280, 2006. ,
ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model, J Control Release, vol.108, pp.460-471, 2005. ,
Extracellular ATP: effects, sources and fate, Biochem J, vol.233, pp.309-319, 1986. ,
Purinergic signaling during inflammation, N Engl J Med, vol.367, pp.2322-2333, 2012. ,
Liposomes, an interesting tool to deliver a bioenergetic substrate (ATP). in vitro and in vivo studies, J Drug Target, vol.2, pp.443-448, 1994. ,
Encapsulation of ATP into liposomes by different methods: optimization of the procedure, J Microencapsul, vol.21, pp.251-261, 2004. ,
Adenosine triphosphate liposomes: encapsulation and distribution studies, Pharm Res, vol.7, pp.553-557, 1990. ,
Acute adenosinergic cardioprotection in ischemic-reperfused hearts, Am J Physiol Heart Circ Physiol, vol.285, pp.1797-1818, 2003. ,
Adenosine: an old drug newly discovered, Anesthesiology, vol.111, pp.904-915, 2009. ,
Adenosine: trigger and mediator of cardioprotection, Basic Res Cardiol, vol.103, pp.203-215, 2008. ,
Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial, Eur Heart J, vol.27, pp.2400-2405, 2006. ,
A randomized, double-blinded, placebocontrolled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II), J Am Coll Cardiol, vol.45, pp.1775-1780, 2005. ,
Beneficial effect of adenosine on myocardial perfusion in patients treated with primary percutaneous coronary intervention for acute myocardial infarction, Clin Exp Pharmacol Physiol, vol.39, pp.247-252, 2012. ,
Prolonged targeting of ischemic/reperfused myocardium by liposomal adenosine augments cardioprotection in rats, J Am Coll Cardiol, vol.53, pp.709-717, 2009. ,
Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles, Int J Nanomedicine, vol.7, pp.1671-1678, 2012. ,
Amorphous silica nanoparticles impair vascular homeostasis and induce systemic inflammation, Int J Nanomedicine, vol.9, pp.2779-2789, 2014. ,
Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK/Nrf2 pathway and nuclear factor-kappaB signaling, Int J Nanomedicine, vol.10, pp.1463-1477, 2015. ,
Imatinib mesylate-incorporated nanoparticleeluting stent attenuates in-stent neointimal formation in porcine coronary arteries, J Atheroscler Thromb, vol.18, pp.1043-1053, 2011. ,
Pitavastatin-incorporated nanoparticle-eluting stents attenuate in-stent stenosis without delayed endothelial healing effects in a porcine coronary artery model, J Atheroscler Thromb, vol.20, pp.32-45, 2013. ,
Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study, Clin Cardiol, vol.30, pp.165-170, 2007. ,
Nanotechnology for the treatment of coronary in stent restenosis: a clinical perspective, Vasc Cell, vol.3, 2011. ,
Nanoparticle drug-and gene-eluting stents for the prevention and treatment of coronary restenosis, Theranostics, vol.4, pp.175-200, 2014. ,
Drug-and Gene-eluting Stents for Preventing Coronary Restenosis, Chonnam Med J, vol.53, pp.14-27, 2017. ,
Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study, Regen Med, vol.9, pp.269-278, 2014. ,
First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction, J Am Coll Cardiol, vol.59, pp.539-540, 2012. ,
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI), Circulation, vol.106, pp.3009-3017, 2002. ,
Repeated intracoronary infusion of peripheral blood stem cells with G-CSF in patients with refractory ischemic heart failure--a pilot study, Circ J, vol.75, pp.955-963, 2011. ,
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial, Lancet, vol.379, pp.895-904, 2012. ,
Cell-based VEGF delivery prevents donor cell apoptosis after transplantation, Ann Thorac Surg, vol.83, pp.1233-1234, 2007. ,
Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty, J Thorac Cardiovasc Surg, vol.132, pp.628-632, 2006. ,
Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery, J Am Coll Cardiol, vol.54, pp.1619-1626, 2009. ,
Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction, J Nucl Med, vol.47, pp.1295-1301, 2006. ,
Magnetic targeting of cardiospherederived stem cells with ferumoxytol nanoparticles for treating rats with myocardial infarction, Biomaterials, vol.35, pp.8528-8539, 2014. ,
Magnetically Targeted Stem Cell Delivery for Regenerative Medicine, J Funct Biomater, vol.6, pp.526-546, 2015. ,
Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium, Circulation, vol.116, pp.38-45, 2007. ,
Magnetic targeting enhances retrograde cell retention in a rat model of myocardial infarction, Stem Cell Res Ther, vol.4, p.149, 2013. ,
Can magnetic targeting of magnetically labeled circulating cells optimize intramyocardial cell retention?, Cell Transplant, vol.21, pp.679-691, 2012. ,
In vivo magnetic resonance imaging of injected mesenchymal stem cells in rat myocardial infarction; simultaneous cell tracking and left ventricular function measurement, Int J Cardiovasc Imaging, vol.25, issue.1, pp.99-109, 2009. ,
Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation, NMR Biomed, vol.18, pp.362-370, 2005. ,
Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart, Circulation, vol.117, pp.1555-1562, 2008. ,
Comparison of optical bioluminescence reporter gene and superparamagnetic iron oxide MR contrast agent as cell markers for noninvasive imaging of cardiac cell transplantation, Mol Imaging Biol, vol.11, pp.178-187, 2009. ,
Novel MRI Contrast Agent from Magnetotactic Bacteria Enables In Vivo Tracking of iPSC-derived Cardiomyocytes, Sci Rep, vol.6, p.26960, 2016. ,
Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction, Circ Res, vol.106, pp.1570-1581, 2010. ,
Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion, Cell Transplant, vol.21, pp.1121-1135, 2012. ,
Magnetic antibody-linked nanomatchmakers for therapeutic cell targeting, Nat Commun, vol.5, p.4880, 2014. ,
Mesenchymal stem cell-loaded cardiac patch promotes epicardial activation and repair of the infarcted myocardium, J Cell Mol Med, 2017. ,
Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction, Proc Natl Acad Sci U S A, vol.103, pp.8155-8160, 2006. ,
Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs, Circulation, vol.122, pp.132-141, 2010. ,
Epicardial FSTL1 reconstitution regenerates the adult mammalian heart, Nature, vol.525, pp.479-485, 2015. ,
A comparison of electrospun polymers reveals poly(3-hydroxybutyrate) fiber as a superior scaffold for cardiac repair, Stem Cells Dev, vol.23, pp.1479-1490, 2014. ,
In vivo evaluation of a porous, elastic, biodegradable patch for reconstructive cardiac procedures, Ann Thorac Surg, vol.83, pp.648-654, 2007. ,
Transplantation of mesenchymal stem cells within a poly(lactide-co-epsilon-caprolactone) scaffold improves cardiac function in a rat myocardial infarction model, Eur J Heart Fail, vol.11, pp.147-153, 2009. ,
Stem cell-loaded nanofibrous patch promotes the regeneration of infarcted myocardium with functional improvement in rat model, Acta Biomater, vol.10, pp.2727-2738, 2014. ,
Effects of cardiac patches engineered with bone marrowderived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model, Biomaterials, vol.28, pp.641-649, 2007. ,
Nanowired three-dimensional cardiac patches, Nat Nanotechnol, vol.6, pp.720-725, 2011. ,
Gold nanoparticle-decellularized matrix hybrids for cardiac tissue engineering, Nano Lett, vol.14, pp.5792-5796, 2014. ,
Electrically conductive gold nanoparticle-chitosan thermosensitive hydrogels for cardiac tissue engineering, Mater Sci Eng C Mater Biol Appl, vol.63, pp.131-141, 2016. ,
Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function, Nat Mater, vol.15, pp.679-685, 2016. ,
Developing injectable nanomaterials to repair the heart, Curr Opin Biotechnol, vol.34, pp.225-231, 2015. ,
Integration of mesenchymal stem cells with nanobiomaterials for the repair of myocardial infarction, Adv Drug Deliv Rev, vol.95, pp.15-28, 2015. ,
Heart regeneration after myocardial infarction using synthetic biomaterials, J Control Release, vol.203, pp.23-38, 2015. ,
, , 2016.
Cardiac regeneration using pluripotent stem cells--progression to large animal models, Stem Cell Res, vol.13, pp.654-665, 2014. ,
Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration, Nanomedicine, vol.11, pp.1039-1046, 2015. ,
Distribution of Systemically Administered Nanoparticles Reveals a Size-Dependent Effect Immediately following Cardiac Ischaemia-Reperfusion Injury, Sci Rep, vol.6, p.25613, 2016. ,
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents, Crit Rev Ther Drug Carrier Syst, vol.18, pp.567-606, 2001. ,
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity, Toxicology, vol.216, pp.106-121, 2005. ,
Liposomal Formulations in Clinical Use: An Updated Review, Pharmaceutics, vol.9, 2017. ,
Cardiotoxicity of nano-particles, Life Sci, vol.165, pp.91-99, 2016. ,
Silica nanoparticles induce cardiotoxicity interfering with energetic status and Ca2+ handling in adult rat cardiomyocytes, Am J Physiol Heart Circ Physiol, vol.312, pp.645-661, 2017. ,
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury, Nat Nanotechnol, vol.9, pp.1054-1062, 2014. ,
A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity, Proc Natl Acad Sci U S A, vol.111, pp.217-226, 2014. ,
A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics and the tubular cell adaptation to injury, Shock, vol.41, p.3, 2014. ,
, Nanoplumbers: biomaterials to fight cardiovascular diseases. Materials Today, vol.21, pp.122-143, 2018.
Cytokine-mediated inflammation in acute lung injury, Cytokine & growth factor reviews, vol.14, pp.523-535, 2003. ,
The immunopathology of sepsis and potential therapeutic targets, Nature Reviews Immunology, vol.17, p.407, 2017. ,
Oxidative stress in sepsis: pathophysiological implications justifying antioxidant cotherapy, Burns, vol.43, pp.471-485, 2017. ,
Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxidative medicine and cellular longevity, 2016. ,
The role of oxidative stress during inflammatory processes, Biological chemistry, vol.395, pp.203-230, 2014. ,
Cross talk between ER stress, oxidative stress, and inflammation in health and disease, Stress Responses, pp.205-214, 2015. ,
Corticosteroids in septic shock: a systematic review and network meta-analysis, Critical Care, vol.21, p.78, 2017. ,
Regulation of inflammation by adenosine, Frontiers in immunology, vol.4, p.85, 2013. ,
Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice, The Journal of Immunology, vol.157, pp.4634-4640, 1996. ,
The disappearance of adenosine from blood and platelet suspension in relation to the platelet cyclic AMP content, Acta physiologica scandinavica, vol.129, pp.189-194, 1987. ,
The cardiac effects of adenosine, Progress in cardiovascular diseases, vol.32, pp.73-97, 1989. ,
Antioxidants, inflammation and cardiovascular disease, World journal of cardiology, vol.6, p.462, 2014. ,
Decreased antioxidant status and increased lipid peroxidation in patients with septic shock and secondary organ dysfunction, Critical care medicine, vol.23, pp.646-651, 1995. ,
Antioxidant supplementation in sepsis and systemic inflammatory response syndrome, Critical care medicine, vol.35, pp.584-590, 2007. ,
Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk, Critical care medicine, vol.24, pp.392-397, 1996. ,
Bench-to-bedside review: sepsis-from the redox point of view, Critical Care, vol.15, p.230, 2011. ,
Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study, Chest, vol.151, pp.1229-1238, 2017. ,
A unifying view of ageing and disease: the double-agent theory, Journal of Theoretical Biology, vol.225, pp.531-540, 2003. ,
Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles, Journal of Controlled Release, 2019. ,
URL : https://hal.archives-ouvertes.fr/cea-02294923
A robust scoring system to evaluate sepsis severity in an animal model, BMC research notes, vol.7, p.233, 2014. ,
Squalenoylation: a generic platform for nanoparticular drug delivery, Journal of controlled release, vol.161, pp.609-618, 2012. ,
Role of vitamin E in preventing the oxidation of low-density lipoprotein. The American journal of clinical nutrition, vol.53, p.25, 1991. ,
Targeting ?1-integrin inhibits vascular leakage in endotoxemia, Proceedings of the National Academy of Sciences, vol.115, p.26, 2018. ,
The enhanced permeability retention effect: a new paradigm for drug targeting in infection, Journal of Antimicrobial Chemotherapy, vol.68, p.27, 2012. ,
, Free radicals in biology and medicine, 2015.
Transport mechanisms of squalenoyladenosine nanoparticles across the blood-brain barrier, Chemistry of Materials, vol.27, pp.3636-3647, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02399979
Bench-to-bedside review: targeting antioxidants to mitochondria in sepsis, Critical care, vol.14, p.230, 2010. ,
Squalene-adenosine nanoparticles: ligands of adenosine receptors or adenosine prodrug?, Journal of Pharmacology and Experimental Therapeutics, vol.369, pp.144-151, 2019. ,
Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages, Journal of Biological Chemistry, vol.275, pp.6259-6266, 2000. ,
Lipopolysaccharide-induced expression of interferon-? mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages, Journal of Biological Chemistry, vol.276, pp.47950-47957, 2001. ,
Nitric oxide production and signaling in inflammation, Current Drug Targets-Inflammation & Allergy, vol.4, pp.471-479, 2005. ,
Inflammation in atherosclerosis and implications for therapy, Circulation, vol.109, 2004. ,
Targeted interleukin-10 nanotherapeutics developed with a microfluidic chip enhance resolution of inflammation in advanced atherosclerosis, ACS nano, vol.10, pp.5280-5292, 2016. ,
, Molecular imaging of angiogenesis in early-stage atherosclerosis with ?v?3-integrin-targeted nanoparticles, vol.108, pp.2270-2274, 2003.
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice, Science translational medicine, vol.7, pp.275-220, 2015. ,
Atherosclerotic plaque targeting mechanism of long-circulating nanoparticles established by multimodal imaging, ACS nano, vol.9, pp.1837-1847, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01850477
Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques, Journal of the American Chemical Society, vol.126, pp.16316-16317, 2004. ,
Perspectives and opportunities for nanomedicine in the management of atherosclerosis, Nature Reviews Drug Discovery, vol.10, p.835, 2011. ,
HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages, Bioconjugate chemistry, vol.26, pp.443-451, 2015. ,
The role of lipids and lipoproteins in atherosclerosis, 2019. ,
Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery, Nature communications, vol.8, p.15678, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01666114
Circulating lipoproteins: a Trojan horse guiding squalenoylated drugs to LDL-accumulating cancer cells, Molecular Therapy, vol.25, pp.1596-1605, 2017. ,
Role of macrophage scavenger receptors in atherosclerosis, Immunobiology, vol.217, pp.492-502, 2012. ,
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells, Cell, vol.71, pp.343-353, 1992. ,
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arteriosclerosis and thrombosis: a journal of vascular biology, vol.14, pp.133-140, 1994. ,
Stimuli-responsive nanocarriers for drug delivery, Nature materials, vol.12, p.991, 2013. ,
Evolution of macromolecular complexity in drug delivery systems, Nature Reviews Chemistry, vol.1, p.63, 2017. ,
Cancer nanomedicines: so many papers and so few drugs! Advanced drug delivery reviews, vol.65, pp.80-88, 2013. ,
Characterization of nanomedicines: A reflection on a field under construction needed for clinical translation success, Journal of controlled release, 2018. ,
Pulmonary toxicity of instilled silver nanoparticles: influence of size, coating and rat strain, PloS one, vol.10, p.119726, 2015. ,
Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines, Nano Today, vol.11, pp.133-144, 2016. ,
Morphology control of self-deliverable nanodrug with enhanced anticancer efficiency, Colloids and Surfaces B: Biointerfaces, vol.165, pp.345-354, 2018. ,
Translational considerations for cancer nanomedicine, Journal of Controlled Release, vol.146, pp.164-174, 2010. ,
Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics, Nature communications, vol.8, p.777, 2017. ,
Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products? Cancer chemotherapy and pharmacology, vol.66, pp.1173-1184, 2010. ,
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures, Expert opinion on drug delivery, vol.14, pp.851-864, 2017. ,
Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization Laboratory, Integrative Biology, vol.5, p.13, 2012. ,
Squalenoylation: a generic platform for nanoparticular drug delivery, Journal of controlled release, vol.161, pp.609-618, 2012. ,
Squalenoylation of chitosan: a platform for drug delivery?, Biomacromolecules, vol.16, pp.2930-2939, 2015. ,
Squalenoylation: a novel technology for anticancer and antibiotic drugs with enhanced activity, Nanosciences and Nanotechnology, pp.253-272, 2016. ,
Squalenoylation favourably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice, Drug Metabolism and Disposition, 2008. ,
Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy. Cancer letters, vol.334, pp.346-353, 2013. ,
Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury, Nature nanotechnology, vol.9, p.1054, 2014. ,
A new painkiller nanomedicine to bypass the blood-brain barrier and the use of morphine, Science Advances, vol.5, p.5148, 2019. ,
URL : https://hal.archives-ouvertes.fr/tel-02463466
Cleavage of structural proteins during the assembly of the head of bacteriophage T4, nature, vol.227, p.680, 1970. ,
The selective in vitro oxidation of the terminal double bonds in squalene, Tetrahedron Letters, vol.3, pp.121-124, 1962. ,
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2, 3-oxidosqualene cyclase, Journal of the Chemical Society, vol.1, pp.461-469, 1988. ,
Dioxidosqualenes: characterization and activity as inhibitors of 2, 3-oxidosqualene-lanosterol cyclase, The Journal of Organic Chemistry, vol.58, pp.3991-3997, 1993. ,
Simple stereoselective version of the Claisen rearrangement leading to trans-trisubstituted olefinic bonds. Synthesis of squalene, Journal of the American Chemical Society, vol.92, pp.741-743, 1970. ,
Synthesis and Cytotoxic Activity of Self-Assembling Squalene Conjugates of 3-[(Pyrrol-2-yl) methylidene]-2, 3-dihydro-1H-indol-2-one Anticancer Agents, European Journal of Organic Chemistry, pp.202-212, 2015. ,
Extracellular adenosineinduced apoptosis in mouse neuroblastoma cells studies on involvement of adenosine receptors and adenosine uptake1, Biochemical pharmacology, vol.61, pp.417-425, 2001. ,
Adenosine stimulates proliferation of human endothelial cells in culture, American Journal of Physiology-Heart and Circulatory Physiology, vol.265, pp.131-138, 1993. ,
Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer research, vol.58, pp.3181-3187, 1998. ,
Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by isoproterenol, Experimental cell research, vol.257, pp.111-126, 2000. ,
Induction of Apoptosis in HL-60 Human Promyelocytic Leukemia Cells by Adenosine A3Receptor Agonists. Biochemical and biophysical research communications, vol.219, pp.904-910, 1996. ,
Assessment of the cytoprotective role of adenosine in an in vitro cellular model of myocardial ischemia, European journal of pharmacology, vol.452, pp.145-154, 2002. ,
Adenosine, oxidative stress and cytoprotection, The Japanese Journal of Pharmacology, vol.86, pp.265-274, 2001. ,
Regulation of adenosine concentration and cytoprotective effects of novel reversible adenosine deaminase inhibitors, Journal of Pharmacology and Experimental Therapeutics, vol.283, pp.1230-1238, 1997. ,
Adenosine A3 receptors: novel ligands and paradoxical effects, Trends in pharmacological sciences, vol.19, pp.184-191, 1998. ,
Opposing effects of adenosine on the survival of glial cells exposed to chemical ischemia, Journal of neuroscience research, vol.62, pp.539-546, 2000. ,
Squalene-adenosine nanoparticles: ligands of adenosine receptors or adenosine prodrug? The Journal of pharmacology and experimental therapeutics, 2019. ,
Biomolecular coronas provide the biological identity of nanosized materials, Nature nanotechnology, vol.7, p.779, 2012. ,
Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo, Journal of controlled release, vol.287, pp.121-131, 2018. ,
Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles, ACS nano, vol.8, pp.2439-2455, 2014. ,
Exploring cellular interactions of liposomes using protein corona fingerprints and physicochemical properties, ACS nano, vol.10, pp.3723-3737, 2016. ,
Prediction of nanoparticles-cell association based on corona proteins and physicochemical properties, Nanoscale, vol.7, pp.9664-9675, 2015. ,
Stereoselective syntheses of 1, 24-dihydroxy squalene 2, 3; 22, 23-dioxides by double sharpless epoxidation, Tetrahedron letters, vol.38, pp.383-386, 1997. ,
Squalene-hopene cyclase: final deprotonation reaction, conformational analysis for the cyclization of (3 R, S)-2, 3-oxidosqualene and further evidence for the requirement of an isopropylidene moiety both for initiation of the polycyclization cascade and for the formation of the 5-membered E-ring, Organic & biomolecular chemistry, vol.2, pp.1456-1470, 2004. ,
Squalene versus cholesterol: Which is the best nanocarrier for the delivery to cells of the anticancer drug gemcitabine?, Comptes Rendus Chimie, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02349745
Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery, Nature communications, vol.8, p.15678, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01666114
Transport mechanisms of squalenoyladenosine nanoparticles across the blood-brain barrier, Chemistry of Materials, vol.27, pp.3636-3647, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02399979
Detoxification of gold nanorods by treatment with polystyrenesulfonate, ACS nano, vol.2, pp.2481-2488, 2008. ,
Controlled release of biologically active silver from nanosilver surfaces, ACS nano, vol.4, pp.6903-6913, 2010. ,
Toxicity of an engineered nanoparticle (fullerene, C60) in two aquatic species, Daphnia and fathead minnow, Marine Environmental Research, vol.62, p.50, 2006. ,
Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA, International Journal of Pharmaceutics, vol.139, pp.69-78, 1996. ,
Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass, Environmental health perspectives, vol.112, p.1058, 2004. ,
Drug delivery: too much complexity, not enough reproducibility?, Angewandte Chemie International Edition, vol.56, pp.15170-15171, 2017. ,
Closing the gap for generic nanomedicines, Chemical Engineering News, vol.92, pp.10-13, 2014. ,
A2B adenosine receptors in immunity and inflammation, Trends in immunology, vol.30, pp.263-270, 2009. ,
Ischemia/reperfusion injury: the role of immune cells, World journal of cardiology, vol.2, p.325, 2010. ,
Selective activation of adenosine A2A receptors on immune cells by a CD73-dependent prodrug suppresses joint inflammation in experimental rheumatoid arthritis, Science translational medicine, vol.4, pp.146-108, 2012. ,
Adenosine receptors as therapeutic targets, Nature reviews Drug discovery, vol.5, p.247, 2006. ,
Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning, Cardiovascular research, vol.26, pp.456-461, 1992. ,
Adenosine: an endogenous regulator of innate immunity, Trends in immunology, vol.25, pp.33-39, 2004. ,
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases, Nature reviews Drug discovery, vol.7, p.759, 2008. ,
Cardiovascular effects of adenosine infusion in man and their modulation by dipyridamole. Life sciences, vol.39, pp.2229-2236, 1986. ,
Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells, Molecular pharmaceutics, vol.6, pp.928-939, 2009. ,
Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance, Journal of Controlled Release, vol.136, pp.21-29, 2009. ,
Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study, Chest, vol.151, pp.1229-1238, 2017. ,
Mitochondrial dysfunction in cardiac disease: ischemia-reperfusion, aging, and heart failure, Journal of molecular and cellular cardiology, vol.33, pp.1065-1089, 2001. ,
Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury, International journal of cardiology, vol.86, pp.41-59, 2002. ,
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation, The Journal of clinical investigation, vol.104, pp.541-549, 1999. ,
The pathophysiological role of peroxynitrite in shock, inflammation, and ischemiareperfusion injury, Shock, vol.6, pp.79-88, 1996. ,
Resveratrol attenuates inflammation in the rat heart subjected to ischemia-reperfusion: Role of the TLR4/NF-?B signaling pathway, Molecular medicine reports, vol.11, pp.1120-1126, 2015. ,
ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model, Journal of controlled release, vol.108, pp.460-471, 2005. ,
Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery, Nature communications, vol.8, p.15678, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01666114
Circulating lipoproteins: a Trojan horse guiding squalenoylated drugs to LDL-accumulating cancer cells, Molecular Therapy, vol.25, pp.1596-1605, 2017. ,
The role of lipids and lipoproteins in atherosclerosis, 2019. ,
Atherosclerosis-an inflammatory disease, New England journal of medicine, vol.340, pp.115-126, 1999. ,
Nanoparticle targeting of neutrophils for improved cancer immunotherapy, Advanced healthcare materials, vol.5, pp.1088-1093, 2016. ,
Neutrophil-mediated delivery of therapeutic nanoparticles across blood vessel barrier for treatment of inflammation and infection, ACS nano, vol.9, p.24, 2015. ,
Targeting ?1-integrin inhibits vascular leakage in endotoxemia, Proceedings of the National Academy of Sciences, vol.115, p.25, 2018. ,
Sepsis and endothelial permeability, vol.363, p.689, 2010. ,
Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration, Science translational medicine, vol.3, pp.112-122, 2011. ,
Endothelial permeability in atherosclerosis, Arch. Pathol, vol.76, pp.99-105, 1963. ,